T1	Participants 556 595	both patients and dogs with chronic HF.
T2	Participants 206 226	patients and in dogs
T3	Participants 616 740	Six dogs with microembolizations-induced HF and 9 HF patients underwent CCM leads and generator (OPTIMIZER II) implantation.
